Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Collegium Pharma
(NQ:
COLL
)
35.84
+0.36 (+1.01%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
338,007
Open
35.37
Bid (Size)
35.84 (1)
Ask (Size)
35.88 (14)
Prev. Close
35.48
Today's Range
35.05 - 36.01
52wk Range
20.83 - 40.95
Shares Outstanding
31,959,828
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Collegium to Report First Quarter 2024 Financial Results on May 9, 2024
April 25, 2024
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Critical Insights From Collegium Pharmaceutical Analyst Ratings: What You Need To Know
April 11, 2024
Via
Benzinga
Performance
YTD
+14.76%
+14.76%
1 Month
-10.24%
-10.24%
3 Month
+7.02%
+7.02%
6 Month
+63.65%
+63.65%
1 Year
+56.92%
+56.92%
More News
Read More
Collegium Pharmaceutical, Inc. Announces Redemption of Outstanding 2.625% Convertible Senior Notes Due 2026
April 11, 2024
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Collegium to Participate in 23rd Annual Needham Virtual Healthcare Conference
April 03, 2024
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Where Collegium Pharmaceutical Stands With Analysts
February 23, 2024
Via
Benzinga
Recap: Collegium Pharmaceutical Q4 Earnings
February 22, 2024
Via
Benzinga
Collegium Reports Record Fourth Quarter and Full-Year 2023 Financial Results
February 22, 2024
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Collegium to Report Fourth Quarter and Full-Year 2023 Financial Results on February 22, 2024
February 08, 2024
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Analyst Expectations For Collegium Pharmaceutical's Future
February 02, 2024
Via
Benzinga
Why Collegium Pharmaceutical Shares Are Gaining Today
January 03, 2024
Via
Benzinga
Recap: Collegium Pharmaceutical Q3 Earnings
November 07, 2023
Via
Benzinga
Needham Maintains Buy Rating for Collegium Pharmaceutical: Here's What You Need To Know
August 25, 2023
Via
Benzinga
TDCX Receives Preliminary Non-binding Proposal Letter, Joins Pure Storage, Dyne Therapeutics And Other Big Stocks Moving Higher On Wednesday
January 03, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Collegium Provides 2024 Financial Guidance
January 03, 2024
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Appeals Court Upholds PTAB’s Finding of Invalidity of Purdue’s 961 Patent
November 27, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Collegium Announces $25 Million Accelerated Share Repurchase Program
November 09, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Collegium to Participate in Upcoming Investor Conferences
November 08, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Collegium Reports Third Quarter 2023 Financial Results
November 07, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Collegium to Report Third Quarter 2023 Financial Results on November 7, 2023
October 24, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Collegium Announces 10 Poster Presentations at PAINWeek Conference 2023
August 28, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Collegium Announces Extension of Nucynta Regulatory Exclusivity through July 2026
August 24, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Collegium Announces $50 Million Accelerated Share Repurchase Program
August 07, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Atlassian, Universal Display, Booking, Dropbox And Other Big Stocks Moving Higher On Friday
August 04, 2023
Via
Benzinga
Collegium Reports Record 1H’23 Net Revenue of $280.3 Million, Up 35% Year-over-Year
August 03, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Collegium to Report Second Quarter 2023 Financial Results on August 3, 2023
July 20, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.